Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Minoshima

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2016
SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0Satoshi Minoshima, Alexander E Drzezga, Henryk Barthel, et al.
Journal of Neurotrauma|October 10, 2013
Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veteransEric C Petrie, Donna J Cross, Vasily L Yarnykh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular ImagingKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and educationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Archives of Neurology|September 14, 2011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialSuzanne Craft, Laura D Baker, Thomas J Montine, et al.
The Lancet. Neurology|August 31, 2015
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detectionStefan Teipel, Alexander Drzezga, Michel J Grothe, et al.
Advances in Molecular Imaging|December 23, 2014
FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's DiseaseJohn Murray, Wai H Tsui, Yi Li, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian CancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2011
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0David S W Djang, Marcel J R Janssen, Nicolaas Bohnen, et al.
Science Advances|June 24, 2026
FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2016
SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0Satoshi Minoshima, Alexander E Drzezga, Henryk Barthel, et al.
Journal of Neurotrauma|October 10, 2013
Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veteransEric C Petrie, Donna J Cross, Vasily L Yarnykh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular ImagingKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2013
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and educationKeith A Johnson, Satoshi Minoshima, Nicolaas I Bohnen, et al.
Archives of Neurology|September 14, 2011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialSuzanne Craft, Laura D Baker, Thomas J Montine, et al.
The Lancet. Neurology|August 31, 2015
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detectionStefan Teipel, Alexander Drzezga, Michel J Grothe, et al.
Advances in Molecular Imaging|December 23, 2014
FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's DiseaseJohn Murray, Wai H Tsui, Yi Li, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian CancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2011
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0David S W Djang, Marcel J R Janssen, Nicolaas Bohnen, et al.
Science Advances|June 24, 2026
FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancerNeetu Singh, Esther Need, Ayden Berndt, et al.
Pageof 16